REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Biotechnologines Farmacijos Centras Biotechpharma (Lithuania)

Main Activities: Research and Development in Nanotechnology | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: UAB Biotechnologines Farmacijos Centras Biotechpharma Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

UAB Biotechnologines Farmacijos Centras Biotechpharma is an enterprise in Lithuania, with the main office in Vilnius. The company operates in the Research and Development in Nanotechnology sector. The enterprise was incorporated on July 16, 2004. It currently has a total number of 122 (2025) employees. In 2023, the company reported a net sales revenue drop of 24.91%. UAB Biotechnologines Farmacijos Centras Biotechpharma’s net profit margin increased by 6.06% in 2023.

Headquarters
Mokslininku g. 4
Vilnius; Vilnius county; Postal Code: LT-08412

Contact Details: Purchase the UAB Biotechnologines Farmacijos Centras Biotechpharma report to view the information.

Basic Information
Total Employees:
Purchase the UAB Biotechnologines Farmacijos Centras Biotechpharma report to view the information.
Registered Capital:
Purchase the UAB Biotechnologines Farmacijos Centras Biotechpharma report to view the information.
Financial Auditors:
Purchase the UAB Biotechnologines Farmacijos Centras Biotechpharma report to view the information.
Incorporation Date:
July 16, 2004
Key Executives
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Biotechnologines Farmacijos Centras Biotechpharma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-24.91%
Total operating revenue
-24.91%
Net Profit (Loss) for the Period
-15.54%
Total equity
-2.99%
Net Profit Margin
6.06%
Return on Equity (ROE)
-8%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?